Anastrozole Tablet, Coated
Product Images NDC 65841-743

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Anastrozole (NDC 65841-743). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zydus Lifesciences Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

C3f0c02f 006a 46b1 8f65 D50a8f263c89 08

Anastrozole Tablets are indicated for the treatment of breast cancer in postmenopausal women. Each bottle contains 1000 tablets. The usual dosage instructions are provided in the package insert. It is recommended to store the tablets at controlled room temperature. The tablets are manufactured by Cala Healthcare Ltd. and dispensed as a resistant and consistent dosage form as defined by the USP. It is important to keep this medicine out of reach of children.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.